K Ramalingam1* and P Karnan2
1Mediclone Biotech Research Centre, Chennai-48, Dr. Rai Memorial, Medical Centre (Cancer Treatment and Research), I.E.C Member, India
2Associate Professor, GRT College of Education, Tiruttani, India
*Corresponding Author: K Ramalingam, Mediclone Biotech Research Centre, Chennai-48, Dr. Rai Memorial, Medical Centre (Cancer Treatment and Research), I.E.C Member, India.
Received: January 01, 2022 Published: February 16, 2022
Cancer research towards the goal of Ehrlich’s magic bullets has become an all time exciting and salubrious subject due to novel mechanisms involved in cancer cells which tilt the balance towards their success of survival and failure of novel drugs in the armamentaria of chemotherapy. Still the disease cancer remains as untreatable one beyond the metastatic stage. Both conventional and non conventional bio therapies became in vain futile attempts in rescuing a metastatic cancer patients who is defenseless with poor immune potential and weak and fragile to tolerate further the impacts of cyto-toxic chemotherapy and its side-effects. A meta-analysis of both conventional and non conventional therapies could bring new insights in the research of oncology towards the accomplishment of real-magic bullets. The subtle question that remains is why chemotherapy and radiation fail and why phytotherapy was unrecognized for cancer treatment by FDA USA. This is the utmost important goal in view of the fact (WHO) that almost 50 percent of global population will suffer from cancer disease in the near future.
Keywords: Chemotheraphy; Monoclonal Abs; Interleukines; Neuropeptides; Magic Bullets; Phytochemicals
Citation: K Ramalingam and P Karnan. “Factual Basis of Conventional Therapies in Metastatic Cancer Treatment - An Overview". Acta Scientific Pharmacology 3.3 (2022): 05-07.
Copyright: © 2022 K Ramalingam and P Karnan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.